Somatico Pharmacal Private Limited

Somatico Pharmacal Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1977PTC019812 Incorporated 20 August 1977 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹22.34 Cr
▲ 34.55% YoY
Net profit · FY 2025
₹45.77 Lakh
Net margin 2%
EBITDA · FY 2025
₹67.18 Lakh
EBITDA margin 3%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹16 Lakh
Issued & subscribed
Open charges
₹1.5 Cr
Satisfied ₹3.35 Cr
Company age
49 yrs
Est. 1977
Employees · EPFO
176
Provident fund records

About Somatico Pharmacal Private Limited

Data last updated:

Somatico Pharmacal Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 August 1977 and has been in existence for over 49 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1977PTC019812. Its GSTIN is 27AABCS1242C1ZX (Maharashtra).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹16 Lakh. It is led by directors Samita Harish Chandrashekar Aiyer and Dipali Amey Rao.

Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. C – 469 MIDC – Ttc Industrial Area Pawane, Navi Mumbai, Maharashtra, India – 400705.

As per the financials filed for FY 2025, the company reported a revenue of ₹22.34 Cr. For the same year it recorded a net profit of ₹45.77 Lakh (net margin 2%) and EBITDA of ₹67.18 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 7% over five years.

The company has about 176 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Somatico. As per MCA filings, the company has open charges of ₹1.5 Cr and satisfied charges of ₹3.35 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending.

Somatico Pharmacal Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0193048). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website somaticopharmacal.com.

Company details

CIN U24230MH1977PTC019812
Registration Number 019812
Incorporation Date 20 August 1977
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0193048

Recognitions & Rankings of Somatico Pharmacal

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0193048

Contact details

Somatico Pharmacal Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is somaticopharmacal.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. C – 469 MIDC – Ttc Industrial Area Pawane, Navi Mumbai, Maharashtra, India – 400705
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Somatico Pharmacal Private Limited, buy the company report.

Comprehensive company report
Somatico Pharmacal Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Somatico Pharmacal operates one associated brand: Somatico. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and sales in therapy areas like respiratory and pain management in India.somaticopharmacal.com

Business activity

The main business activity of Somatico Pharmacal is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Somatico Pharmacal Private Limited, buy the company report.

Financials of Somatico Pharmacal Private Limited

FY 2025 filings available

Somatico Pharmacal Private Limited reported revenue of ₹22.34 Cr for FY 2025.

Revenue · FY 2025
₹22.34 Cr
Net profit · FY 2025
₹45.77 Lakh margin 2%
EBITDA · FY 2025
₹67.18 Lakh margin 3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 11%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 162%
5 years · compounded
▼ 9%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹67.18 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹45.77 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3%
Net Profit Margin2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Somatico Pharmacal Private Limited, buy the company report.

Board of directors of Somatico Pharmacal Private Limited

Somatico Pharmacal has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Samita Harish Chandrashekar AiyerDirector01 Sep 197947 Years 2 MonthsCurrent
Dipali Amey RaoDirector09 Jan 20197 Years 9 MonthsCurrent

Peer comparison

Somatico Pharmacal Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Celera Pharma Private Limited₹22.48 Cr (FY 2025)23.0%Hyderabad, Telangana, India
Khera Pharma Private Limited₹22.37 Cr (FY 2024)-1.0%Ropar, Punjab, India
Somatico Pharmacal Private Limitedthis company₹22.34 Cr (FY 2025)₹45.77 Lakh2%176Navi Mumbai, Maharashtra, India
Shree Signify Exim Private Limited₹22.26 Cr (FY 2024)-13.0%Nagpur, Maharashtra, India
Emmar Drug Links Private Limited₹22.26 Cr (FY 2025)15.0%Kannur, Kerala, India
Kaizen Laboratories Private Limited₹22.16 Cr (FY 2025)15.0%Chennai, Tamil Nadu, India
Medibox Pharma Private Limited₹22.14 Cr (FY 2025)-37.0%Delhi, India

To see the full peer comparison of Somatico Pharmacal Private Limited, buy the company report.

Auditor

Somatico Pharmacal Private Limited is audited by N. J. Mahtani & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
N. J. Mahtani & Co.FY 20230124930W

Shareholding

The shareholding of Somatico Pharmacal Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Somatico Pharmacal Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.5 Cr
Satisfied charges
₹3.35 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹1.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Sep 2020100364283Hdfc Bank Limited₹1.5 CrOpen
16 Feb 2019100244727Hdfc Bank Limited₹30 LakhSatisfied
20 Mar 2018100167546Others₹10 LakhSatisfied
18 Jul 2017100113584Others₹8 LakhSatisfied
04 Jul 2017100113585Others₹10 LakhSatisfied

To see the full charge records of Somatico Pharmacal Private Limited, buy the company report.

Total charge records: 11 View all charges

MSME payment delays

Somatico Pharmacal Private Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 35 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 6)

SupplierAmount dueDue sinceReported on
Maxcure Nutravedics Limited
Lyra Laboratories Private Limited
MDC Pharmaceuticals Limited
Unimarck Healthcare Limited
Bothra Logistics

To see the full MSME payment records of Somatico Pharmacal Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Somatico Pharmacal Private Limited has a workforce of 176 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.

Employee count
176
Active EPFO establishments
1
Employee growth
14.29%

GST

Somatico Pharmacal has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AABCS1242C1ZXMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Somatico Pharmacal Private Limited, buy the company report.

Recent activity

Somatico Pharmacal Private Limited has 10 board changes on record since 1979: 2 appointments and 8 cessations. The latest: Rohidas Rangnath Date ceased to be Director on 01 Apr 2022.

AGM
Somatico Pharmacal Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Filing
Somatico Pharmacal Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge registered on 16 Feb 2019 via Charge ID 100244727 with Hdfc Bank Limited was fully satisfied on 07 Feb 2024.
Ceased
Rohidas Rangnath Date ceased to be Director.
Charges
A charge registered on 02 May 2016 via Charge ID 100042472 with Hdfc Bank Limited was fully satisfied on 03 Aug 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 100364283 was registered on 02 Sep 2020.
Charges
A charge registered on 20 Mar 2018 via Charge ID 100167546 with Others was fully satisfied on 11 Aug 2020.
Ceased
Anuradha Ramani Aiyer ceased to be Director.
Ceased
Dipali Amey Rao ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100244727 was registered on 16 Feb 2019.
Appointed
Dipali Amey Rao was appointed as Director.
Charges
A charge registered on 23 Nov 2015 via Charge ID 100042268 with Hdfc Bank Limited was fully satisfied on 05 Dec 2018.

23 earlier events are in the company report.

Frequently asked questions

Somatico Pharmacal is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 August 1977 (49+ years old) and is registered under CIN U24230MH1977PTC019812.

Somatico Pharmacal has 2 current directors:

The latest financial statements of Somatico Pharmacal on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Somatico Pharmacal is 27AABCS1242C1ZX, registered in Maharashtra.

The CIN (Corporate Identification Number) of Somatico Pharmacal is U24230MH1977PTC019812. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Somatico Pharmacal has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Somatico Pharmacal was incorporated on 20 August 1977, making it 49+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Somatico Pharmacal by revenue are Celera Pharma Private Limited, Khera Pharma Private Limited, Shree Signify Exim Private Limited, Emmar Drug Links Private Limited, Kaizen Laboratories Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Rohidas Rangnath Date ceased to be Director on 01 Apr 2022. Anuradha Ramani Aiyer ceased to be Director on 16 Jan 2020. Dipali Amey Rao ceased to be Additional Director on 28 Sep 2019. Somatico Pharmacal has 10 board changes on record in total.

Yes, Somatico Pharmacal is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0193048).

Somatico Pharmacal has 5 MSME Form 1 returns on record between 2019 and 2021, listing 35 overdue payments to 6 micro and small suppliers. The latest return was filed on 13 May 2021.

Somatico Pharmacal can be reached through the website somaticopharmacal.com. Its registered office is in Navi Mumbai, Maharashtra, India.